Cheryl Cohen, Director at ImmunityBio, Inc. (IBRX), sold 131,210 shares at $9.50 ($1.2M) on 2026-07-02, disclosed to the SEC on 2026-07-06.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IBRX | SELL | 2021-08-19 | $900K | — | Filing → |
| NK | SELL | 2020-08-13 | $299K | — | Filing → |
| VTL | SELL | 2018-09-14 | $2K | — | Filing → |